71 related articles for article (PubMed ID: 27798873)
1. A Panel of Serum Biomarkers (GastroPanel®) in Non-invasive Diagnosis of Atrophic Gastritis. Systematic Review and Meta-analysis.
Syrjänen K
Anticancer Res; 2016 Oct; 36(10):5133-5144. PubMed ID: 27798873
[TBL] [Abstract][Full Text] [Related]
2. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis.
Zagari RM; Rabitti S; Greenwood DC; Eusebi LH; Vestito A; Bazzoli F
Aliment Pharmacol Ther; 2017 Oct; 46(7):657-667. PubMed ID: 28782119
[TBL] [Abstract][Full Text] [Related]
3. GastroPanel® Biomarker Assay: The Most Comprehensive Test for
Syrjänen K; Eskelinen M; Peetsalu A; Sillakivi T; Sipponen P; Härkönen M; Paloheimo L; Mäki M; Tiusanen T; Suovaniemi O; DiMARIO F; Fan ZP
Anticancer Res; 2019 Mar; 39(3):1091-1104. PubMed ID: 30842138
[TBL] [Abstract][Full Text] [Related]
4.
MÄki M; SÖderstrÖm D; Paloheimo L; Hendolin P; Suovaniemi O; SyrjÄnen K
Anticancer Res; 2020 Nov; 40(11):6387-6398. PubMed ID: 33109577
[TBL] [Abstract][Full Text] [Related]
5. High-Negative Anti-
Inoue M; Sawada N; Goto A; Shimazu T; Yamaji T; Iwasaki M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):420-426. PubMed ID: 31826914
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori antibody and pepsinogen testing for predicting gastric microbiome abundance.
Choi S; Lee JG; Lee AR; Eun CS; Han DS; Park CH
PLoS One; 2019; 14(12):e0225961. PubMed ID: 31800638
[TBL] [Abstract][Full Text] [Related]
7. Gastric Cancer Screening by Combined Determination of Serum
Chen XZ; Huang CZ; Hu WX; Liu Y; Yao XQ
Chin Med J (Engl); 2018 May; 131(10):1232-1239. PubMed ID: 29722342
[TBL] [Abstract][Full Text] [Related]
8. Serum pepsinogen and gastrin-17 as potential biomarkers for pre-malignant lesions in the gastric corpus.
Loong TH; Soon NC; Nik Mahmud NRK; Naidu J; Rani RA; Abdul Hamid N; Elias MH; Mohamed Rose I; Tamil A; Mokhtar NM; Raja Ali RA
Biomed Rep; 2017 Nov; 7(5):460-468. PubMed ID: 29181158
[TBL] [Abstract][Full Text] [Related]
9. A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Bostick RM; Wu X; Yuan Y
Am J Gastroenterol; 2017 May; 112(5):704-715. PubMed ID: 28323271
[TBL] [Abstract][Full Text] [Related]
10. A panel of stomach-specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence area.
Chapelle N; Petryszyn P; Blin J; Leroy M; Le Berre-Scoul C; Jirka I; Neunlist M; Moussata D; Lamarque D; Olivier R; Tougeron D; Mosnier JF; Matysiak-Budnik T
Helicobacter; 2020 Oct; 25(5):e12727. PubMed ID: 32700438
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy.
Bang CS; Lee JJ; Baik GH
J Clin Med; 2019 May; 8(5):. PubMed ID: 31083485
[TBL] [Abstract][Full Text] [Related]
12. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention.
Thrift AP; Wenker TN; El-Serag HB
Nat Rev Clin Oncol; 2023 May; 20(5):338-349. PubMed ID: 36959359
[TBL] [Abstract][Full Text] [Related]
13. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and
Koivurova OP; Koskela R; Blomster T; Ala-Rämi A; Lumme H; Kettunen O; Hukkanen J; Karttunen TJ; Mäkinen M; Ronkainen J; Syrjänen K
Anticancer Res; 2021 Nov; 41(11):5527-5537. PubMed ID: 34732423
[TBL] [Abstract][Full Text] [Related]
14. Value of Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and
Sivandzadeh GR; Zadeh Fard SA; Zahmatkesh A; Anbardar MH; Lankarani KB
Middle East J Dig Dis; 2023 Jan; 15(1):37-44. PubMed ID: 37547155
[No Abstract] [Full Text] [Related]
15. Update in Molecular Aspects and Diagnosis of Autoimmune Gastritis.
Iwamuro M; Tanaka T; Otsuka M
Curr Issues Mol Biol; 2023 Jun; 45(7):5263-5275. PubMed ID: 37504250
[TBL] [Abstract][Full Text] [Related]
16. Controlling Gastric Cancer in a World of Heterogeneous Risk.
Huang RJ; Laszkowska M; In H; Hwang JH; Epplein M
Gastroenterology; 2023 Apr; 164(5):736-751. PubMed ID: 36706842
[TBL] [Abstract][Full Text] [Related]
17. Chinese integrated guideline on the management of gastric precancerous conditions and lesions.
Wang P; Li P; Chen Y; Li L; Lu Y; Zhou W; Bian L; Zhang B; Yin X; Li J; Chen J; Zhang S; Shi Y; Tang X
Chin Med; 2022 Dec; 17(1):138. PubMed ID: 36517854
[TBL] [Abstract][Full Text] [Related]
18. Panel of serum biomarkers (GastroPanel) in diagnosis of atrophic gastritis and
Wu D; Shi A; Wang H; Yu X
BMJ Open; 2022 Sep; 12(9):e062849. PubMed ID: 36171026
[TBL] [Abstract][Full Text] [Related]
19. Introducing the Sanguis-Filum for Detection of Gastric Mucosal Lesions Prior to Endoscopy: A Study Protocol.
Kayamba V; Kelly P
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626320
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.
Ansari S; Yamaoka Y
Clin Microbiol Rev; 2022 Sep; 35(3):e0025821. PubMed ID: 35404105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
